Correlation Between Erasca and Immunic
Can any of the company-specific risk be diversified away by investing in both Erasca and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and Immunic, you can compare the effects of market volatilities on Erasca and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and Immunic.
Diversification Opportunities for Erasca and Immunic
Good diversification
The 3 months correlation between Erasca and Immunic is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Erasca i.e., Erasca and Immunic go up and down completely randomly.
Pair Corralation between Erasca and Immunic
Given the investment horizon of 90 days Erasca Inc is expected to generate 0.9 times more return on investment than Immunic. However, Erasca Inc is 1.11 times less risky than Immunic. It trades about -0.02 of its potential returns per unit of risk. Immunic is currently generating about -0.1 per unit of risk. If you would invest 289.00 in Erasca Inc on September 17, 2024 and sell it today you would lose (27.00) from holding Erasca Inc or give up 9.34% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Erasca Inc vs. Immunic
Performance |
Timeline |
Erasca Inc |
Immunic |
Erasca and Immunic Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Erasca and Immunic
The main advantage of trading using opposite Erasca and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.Erasca vs. Puma Biotechnology | Erasca vs. Iovance Biotherapeutics | Erasca vs. Zentalis Pharmaceuticals Llc | Erasca vs. Syndax Pharmaceuticals |
Immunic vs. Generation Bio Co | Immunic vs. Kronos Bio | Immunic vs. Erasca Inc | Immunic vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |